...
首页> 外文期刊>The Journal of Organic Chemistry >Divergent synthesis of 4-epi-fagomine, 3,4-dihydroxypipecolic acid, and a dihydroxyindolizidine and their β-galactosidase inhibitory and immunomodulatory activities
【24h】

Divergent synthesis of 4-epi-fagomine, 3,4-dihydroxypipecolic acid, and a dihydroxyindolizidine and their β-galactosidase inhibitory and immunomodulatory activities

机译:4-表迷迭香,3,4-二羟基哌酸和二羟基吲哚并烷的不同合成及其对β-半乳糖苷酶的抑制和免疫调节活性

获取原文
获取原文并翻译 | 示例

摘要

A divergent asymmetric synthesis of the titled iminosugars has been formulated starting from a chiral homoallyl alcohol as the versatile intermediate. The homoallyl alcohol was prepared by a highly diastereoselective Barbier reaction on a d-glucose-derived aldehyde. The protection of its hydroxyl function followed by reductive ozonolysis of the olefin and a subsequent one-pot three-step protocol involving a Staudinger reaction, reductive amination, and benzyloxy carbonyl protection yielded an important bicyclic furanopiperidine derivative. This was converted to the target compounds by following standard reactions. Among the synthesized compounds, 4-epi-fagomine (2b) was the best β-galactosidase inhibitor, and it also prevented LPS-mediated activation of Raw 264.7 macrophage cells. Its congener, 3,4-dihydroxypipecolic acid (4b) also showed similar trends in its cytokine- and enzyme-inhibitory properties at a low concentration (10 μM) but was proinflammatory at higher concentrations. The bicyclic compound dihydroxyindolizidine (21) reduced the proinflammatory cytokine (IL-1β and TNF-α) levels in the LPS-activated Raw 264.7 cells without showing any enzyme-inhibition activity.
机译:以手性均烯丙基醇为通用中间体,已配制了标题亚氨基糖的多种不对称合成物。通过在衍生自d-葡萄糖的醛上的高度非对映选择性的Barbier反应来制备均烯丙基醇。保护其羟基官能团,然后进行烯烃的还原性臭氧分解,以及随后的一锅三步操作(包括施陶丁格反应,还原胺化和苄氧基羰基保护),产生了重要的双环呋喃并哌啶衍生物。通过以下标准反应将其转化为目标化合物。在合成的化合物中,4-表-fagomine(2b)是最好的β-半乳糖苷酶抑制剂,它还阻止了LPS介导的Raw 264.7巨噬细胞的活化。它的同类物3,4-二羟基哌酸(4b)在低浓度(10μM)时也显示出类似的细胞因子和酶抑制特性趋势,但在较高浓度时具有促炎作用。双环化合物二羟基吲哚并吡啶(21)降低了LPS激活的Raw 264.7细胞中促炎细胞因子(IL-1β和TNF-α)的水平,但未显示任何酶抑制活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号